Athersys (ATHX) Stock Climbs On Strong Results From MultiStem
Athersys, Inc (NASDAQ: ATHX) Athersys is having an incredibly strong day in the market today, and for good reason. The company released data from a Phase 2 clinical trial looking into MultiStem cell therapy which proved to be incredibly positive. Today, we’ll take a look at the results that were released, how the market reacted … Read more